Supernus Pharmaceuticals
SUPN
SUPN
291 hedge funds and large institutions have $1.94B invested in Supernus Pharmaceuticals in 2025 Q1 according to their latest regulatory filings, with 37 funds opening new positions, 109 increasing their positions, 96 reducing their positions, and 34 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
291
Holders Change
-1
Holders Change %
-0.34%
% of All Funds
3.95%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.03%
New
37
Increased
109
Reduced
96
Closed
34
Calls
$579K
Puts
$223K
Net Calls
+$356K
Net Calls Change
-$403K
Top Buyers
| 1 |
SI
Sofinnova Investments
Menlo Park,
California
|
+$17.1M |
| 2 |
KAM
Krensavage Asset Management
New York
|
+$14.1M |
| 3 |
AC
Armistice Capital
New York
|
+$11.8M |
| 4 |
Point72 Asset Management
Stamford,
Connecticut
|
+$9.57M |
| 5 |
JPMorgan Chase & Co
New York
|
+$6.93M |
Top Sellers
| 1 |
Pacer Advisors
Malvern,
Pennsylvania
|
-$39.1M |
| 2 |
WP
Woodline Partners
San Francisco,
California
|
-$15.3M |
| 3 |
PCH
Polar Capital Holdings
London,
United Kingdom
|
-$10.7M |
| 4 |
BlackRock
New York
|
-$10.3M |
| 5 |
Raymond James Financial
St Petersburg,
Florida
|
-$6.85M |
